S&P 500 slides below closely watched threshold

Go back to S&P 500 slides below closely watched threshold

Mizuho Securities Remains Sidelined Following Endo Int'l's (ENDP) Mixed 4Q Results

March 2, 2016 7:10 AM UTC

Mizuho Securities reiterated a Neutral rating on Endo International plc (NASDAQ: ENDP), and cut the price target to $42.00 (from $55.00), following the company's 4Q earnings report. ENDP reported revenues of $1.07B, in-line with consensus' estimate. EPS was reported at $1.36, ahead of expectations of $1.27. ENDP introduced... More

Drexel Hamilton Cuts Price Target on Workday (WDAY) Despite a Strong 4Q Showing

March 1, 2016 9:22 AM UTC

Drexel Hamilton maintained a Buy rating on Workday (NYSE: WDAY), and cut the price target to $88.00 (from $103.00), following the company's 4Q. Workday reported 4Q sales of $323.4 million that beat the Street estimates at $319.6 million. Pro forma EPS of negative $0.01 was also... More

Piper Jaffray Remains Bullish on Endo Int'l (ENDP) Following an In-Line 4Q - PT to $81

March 1, 2016 9:04 AM UTC

Piper Jaffray maintained an Overweight rating on Endo International plc (NASDAQ: ENDP), and cut the price target to $81.00 (from $83.00), following the company's relatively in-line 4Q earnings results. Endo reported 4Q15 non-GAAP EPS of $1.36 on revenues of $1.1B. Sales of Xiaflex in 4Q15 were $50M, up 26% versus 3Q15 sales of $40M, with ENDP citing... More

Needham & Company Reiterates Buy Following Workday's (WDAY) Strong '16 Close

March 1, 2016 8:32 AM UTC

Needham & Company maintained a Buy rating on Workday (NYSE: WDAY), and cut the price target to $80.00 (from $92.00), After the company reported a strong close to FY16. 4Q revenues of $323.4mm came in ahead of Needham's $318mm estimates, While EPS of ($0.01) also beat estimates (-$0.06). WDAY reported its best Financials quarter... More

Piper Jaffray Raises Price Target on Workday (WDAY) Following Solid 4Q Results and Guidance

March 1, 2016 8:07 AM UTC

Piper Jaffray reiterated a Neutral rating on Workday (NYSE: WDAY), and raised the price target to $61.00 (from $48.00), following the company's 4Q earnings report. WDAY beat the top end of revenue guidance by $3M, and logging subscription growth of 44%, overall revenue growth of 43%... More

Leerink Partners Cuts Price Target on Endo Int'l (ENDP) Following 4Q Earnings Report

March 1, 2016 7:50 AM UTC

Leerink Partners maintained an Outperform rating on Endo International plc (NASDAQ: ENDP), and cut the price target to $51.00 (from $64.00), following the company's 4Q earnings report. ENDP generics were unfavorably impacted by increased pricing pressure in pain and commodity products within legacy Qualitest, an... More